The Mounjaro golden dose chart: what it means and how it works

What does the Mounjaro dose chart actually show?

The standard Mounjaro titration schedule runs from 2.5mg upward in 2.5mg steps, with each strength typically held for around four weeks before a prescriber considers moving up. The full ladder is 2.5mg, 5mg, 7.5mg, 10mg, 12.5mg and 15mg. You can read the full breakdown on our Mounjaro dose chart page, which maps each step with the rationale behind it.

The 2.5mg starting pen exists specifically to let your digestive system settle in — nausea and other gut-related effects are most common early on and tend to ease over time. The NHS's tirzepatide information confirms this graduated approach is built into the medicine's licensed use. What the chart cannot tell you is where your personal golden dose sits, because that depends on your individual response, and our Mounjaro golden dose page goes into detail on how people find theirs.

In the SURMOUNT-1 clinical trial, participants who reached 15mg saw average body-weight reductions of around 20–21% over 72 weeks, as reported in the New England Journal of Medicine. But a meaningful number of participants achieve substantial results at lower doses, which is precisely why the golden dose idea resonates so widely.

Why do so many people point to 5mg as the golden dose?

The short answer is that 5mg is where the therapeutic effect becomes noticeable for many people, while the side-effect profile is still gentler than at higher strengths. At 2.5mg the primary goal is tolerance, not maximum effect. Moving to 5mg is often when appetite suppression and slower gastric emptying become genuinely felt in daily life, smaller portions feel satisfying, and the pull toward snacking can ease considerably.

That said, calling 5mg universally "golden" oversimplifies things. Some people find 7.5mg or 10mg to be the point where progress really accelerates without unacceptable side effects. Others tolerate 5mg well and stay there for an extended period as a deliberate plan rather than a pause. Our page on the 5mg golden dose explores this in more detail, and if you are wondering whether staying at 2.5mg for longer than expected is sensible, the page on extended time at 2.5mg is worth reading too.

The NICE appraisal of tirzepatide (TA1026) notes that if less than 5% weight loss has occurred after six months at the highest tolerated dose, continuing treatment should be reviewed. That framing ("highest tolerated") is the real clinical anchor for golden-dose thinking.

How does a prescriber decide when to move up, or stay put?

Every dose decision involves weighing two things: how well you are tolerating the current strength, and whether you are making the progress expected. If nausea, fatigue or gastrointestinal discomfort is still significant after four weeks, a prescriber will often recommend staying at the current dose rather than pushing higher. That extended stay is not failure; it is the medicine working as designed.

At nume, a real clinician reviews your progress before every dose change, not a questionnaire that auto-approves. Our clinical team checks your reported weight, any side effects, and your overall picture before confirming a next step. Evidence of your current dose and progress is required for each increase, which is standard practice for any responsible prescriber.

Oral contraceptive users should note that NHS guidance on tirzepatide advises adding a non-oral method of contraception for the first four weeks of treatment and for four weeks after each dose increase, because absorption of the pill may be reduced. It is a practical point worth building into your planning, especially around dose-change weeks.

A note on timing worth mentioning: if you are thinking about when to start or move up a dose, our prescribers see orders throughout the week, but placing an order before noon Monday to Friday means your consultation is reviewed the same working day. Worth keeping in mind around bank holidays or pay-day weeks when you might be thinking further ahead.

If cost is part of your calculation, our breakdown of Mounjaro pricing in the UK covers what the private market looks like and what a legitimate price should include. For anyone still getting oriented, the Mounjaro overview page covers the medicine from scratch.

Does staying at the golden dose mean you stop titrating?

Not necessarily, though some people do. Staying at a particular strength indefinitely is a valid clinical outcome if weight loss is progressing well, side effects are manageable, and you and your prescriber agree it is the right plan. There is no obligation to reach 15mg. The ceiling dose is there for people who need it, not a destination everyone should aim for.

Equally, if weight loss slows or plateaus, moving up a step may restart progress. The decision is always prescriber-led and personal. What the golden dose chart conversation really reflects is how individual this medicine's journey is: two people on identical doses for identical durations can have quite different experiences. Understanding the schedule, and why you are at the dose you are on, puts you in a much better position to have that conversation with a clinician.

If you want to explore your own options, speaking to our prescribers is a straightforward starting point. You can begin your free consultation and have your situation reviewed the same day by a qualified Independent Prescriber.